|
|
||||||||
Articles |
Parathyroid hormone (PTH)-related protein (PTHrP) is produced in smooth muscles and endothelial cells and is believed to participate in the local regulation of vascular tone. No direct evidence for the activation of endothelium-derived nitric oxide (NO) signaling pathway by PTHrP has been found despite attempts to identify it. Based on direct in situ measurements, it is reported here for the first time that the human PTH/PTHrP receptor analogs, hPTH(1--34) and hPTHrP(1--34), stimulate NO release from a single endothelial cell. A highly sensitive porphyrinic microsensor with a response time of 0.1 ms and a detection limit of 1 nmol/l was used for the measurement of NO. Both hPTH(1--34) and hPTHrP(1--34) stimulated NO release at nanomolar concentrations. The peak concentration of 0.1 micromol/l hPTH(1--34)- and 0.1 micromol/l hPTHrP(1--34)-stimulated NO release was 175+/-9 and 248+/-13 nmol/l respectively. This represents about 30%--40% of maximum NO concentration recorded in the presence of (0.1 micromol/l) calcium ionophore. Two competitive PTH/PTHrP receptor antagonists, 10 micromol/l [Leu(11),d -Trp(12)]-hPTHrP(7--34)amide and 10 micromol/l [Nle(8,18),Tyr(34)]-bPTH(3--34)amide, were equipotent in antagonizing hPTH(1--34)-stimulated NO release; [Leu(11),d -Trp(12)]-hPTHrP(7--34)amide was more potent than [Nle(8,18),Tyr(34)]-bPTH(3--34)amide in inhibiting hPTHrP(1--34)-stimulated NO release. The PKC inhibitor, H-7 (50 micromol/l), did not change hPTH(1--34)- and hPTHrP(1--34)-stimulated NO release, whereas the combined effect of 10 micromol/l of the cAMP antagonist, Rp-cAMPS, and 50 micromol/l of the calmodulin inhibitor, W-7, was additive. The present studies show that both hPTH(1--34) and hPTHrP(1--34) activate NO production in endothelial cells. The activation of NO release is through PTH/PTHrP receptors and is mediated via the calcium/calmodulin pathway.
This article has been cited by other articles:
![]() |
G. Rashid, J. Bernheim, J. Green, and S. Benchetrit Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2831 - 2837. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Mahon, T. M. Bonacci, P. Divieti, and A. V. Smrcka A Docking Site for G Protein {beta}{gamma} Subunits on the Parathyroid Hormone 1 Receptor Supports Signaling through Multiple Pathways Mol. Endocrinol., January 1, 2006; 20(1): 136 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Godler, A. N. Stein, O. Bakharevski, M. M. L. Lindsay, and P. F. J. Ryan Parathyroid hormone-related peptide expression in rat collagen-induced arthritis Rheumatology, September 1, 2005; 44(9): 1122 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gao and J. U. Raj Parathyroid hormone-related protein-mediated responses in pulmonary arteries and veins of newborn lambs Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L60 - L66. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Meziani, B. Van Overloop, F. Schneider, and A. Gairard Parathyroid Hormone-Related Protein-induced Relaxation of Rat Uterine Arteries: Influence of the Endothelium During Gestation Reproductive Sciences, January 1, 2005; 12(1): 14 - 19. [Abstract] [PDF] |
||||
![]() |
R. H. Hastings, F. Araiza, D. W. Burton, M. Bedley, and L. J. Deftos Parathyroid hormone-related protein regulates apoptosis in lung cancer cells through protein kinase A Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1616 - C1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fritsch, V. Lindner, S. Welsch, T. Massfelder, M. Grima, S. Rothhut, M. Barthelmebs, and J.-J. Helwig Intravenous Delivery of PTH/PTHrP Type 1 Receptor cDNA to Rats Decreases Heart Rate, Blood Pressure, Renal Tone, Renin Angiotensin System, and Stress-Induced Cardiovascular Responses J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2588 - 2600. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Olearczyk, M. L. Ellsworth, A. H. Stephenson, A. J. Lonigro, and R. S. Sprague Nitric Oxide Inhibits ATP Release from Erythrocytes J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1079 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Mahon, J. A. Cole, E. D. Lederer, and G. V. Segre Na+/H+ Exchanger-Regulatory Factor 1 Mediates Inhibition of Phosphate Transport by Parathyroid Hormone and Second Messengers by Acting at Multiple Sites in Opossum Kidney Cells Mol. Endocrinol., November 1, 2003; 17(11): 2355 - 2364. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Bakker, M. Joldersma, J. Klein-Nulend, and E. H. Burger Interactive effects of PTH and mechanical stress on nitric oxide and PGE2 production by primary mouse osteoblastic cells Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E608 - E613. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ogata, E. Ritz, G. Odoni, K. Amann, and S. R. Orth Beneficial Effects of Calcimimetics on Progression of Renal Failure and Cardiovascular Risk Factors J. Am. Soc. Nephrol., April 1, 2003; 14(4): 959 - 967. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |